0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

Goodness Growth Holdings Inc

Healthcare US GDNSF

0.63USD
0.05(7.75%)

Last update at 2024-05-16T16:54:00Z

Day Range

0.570.65
LowHigh

52 Week Range

0.090.30
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -36.56444M -29.56847M -14.15219M -57.30949M -0.13934M
Minority interest - - - - -
Net income -42.45744M -33.69047M -22.94219M -57.01049M -0.13934M
Selling general administrative 36.52M 38.84M 39.14M 27.67M 0.14M
Selling and marketing expenses - - - - -
Gross profit 30.91M 19.80M 17.13M 10.84M -
Reconciled depreciation 1.33M 1.44M 1.03M 4.07M 0.00028M
Ebit - -18.99310M -23.04312M -22.36765M 4.60M
Ebitda -12.64125M -17.55128M -8.02816M -48.05958M -0.13907M
Depreciation and amortization - - - - -
Non operating income net other - 1.49M - - -
Operating income -6.93936M -20.48156M -23.04312M -19.06649M -0.13934M
Other operating expenses - 4.08M - - -
Interest expense 22.59M 10.58M 5.10M 5.18M 0.00000M
Tax provision 5.89M 4.12M 8.79M -0.29900M -
Interest income - - - 0.00066M -
Net interest income -22.59355M -10.57537M -5.09585M -5.18306M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 5.46M 8.79M 0.59M 5.20M
Total revenue 74.63M 54.45M 49.21M 29.96M 0.00000M
Total operating expenses 81.57M 40.28M 72.25M 49.02M 0.14M
Cost of revenue 43.72M 32.01M 32.08M 19.11M -
Total other income expense net -7.03153M 1.49M 13.99M -33.05994M -
Discontinued operations - - - - -
Net income from continuing ops -42.45744M -35.02848M -22.94219M -57.01049M -0.13934M
Net income applicable to common shares - -33.69047M -22.94219M -57.47931M -3.07735M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 159.16M 166.97M 102.63M 105.21M 0.15M
Intangible assets 8.78M 10.18M 8.41M 9.00M -
Earning assets - - - - -
Other current assets - 1.56M 6.34M 1.62M 8.30M
Total liab 155.72M 123.96M 40.28M 38.88M 0.01M
Total stockholder equity 3.44M 43.01M 62.35M 66.33M 0.13M
Deferred long term liab - - - - -
Other current liab 1.32M 1.60M 11.07M 0.65M -
Common stock - - - - 41.97M
Capital stock 0.00000M 0.00000M 0.00000M 118.45M 11.02M
Retained earnings -177.88096M -135.42352M -101.73304M -78.79085M -3.07735M
Other liab - - - - 6.78M
Good will 0.18M 0.18M 3.13M 3.13M -
Other assets - 6.96M 5.32M 4.20M 2.29M
Cash 15.15M 15.16M 25.51M 7.64M 0.13M
Cash and equivalents - - - - -
Total current liabilities 29.71M 16.41M 19.94M 3.76M 4.20M
Current deferred revenue - - - - -
Net debt 42.88M 12.17M - - -
Short term debt - - - - -
Short long term debt 11.78M - 2.01M - -
Short long term debt total - - - - -
Other stockholder equity - - - - 2.77M
Property plant equipment - 108.00M 38.73M 41.85M 22.84M
Total current assets 46.73M 41.64M 47.04M 27.25M 41.94M
Long term investments - 3.75M - - -
Net tangible assets - 32.64M 50.80M 36.55M 39.47M
Short term investments - - - - -
Net receivables 1.42M 4.50M 0.99M 1.03M 1.67M
Long term debt 46.25M 27.33M - 1.93M -
Inventory 20.51M 20.42M 12.64M 14.67M 21.38M
Accounts payable 1.91M 14.81M 0.90M 1.36M 2.51M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - -135.42352M - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 109.72M - - -
Deferred long term asset charges - - - - -
Non current assets total 112.43M 1.50M 55.59M 54.06M 0.00111M
Capital lease obligations 81.44M 81.83M 21.20M 29.29M -
Long term debt total - 27.33M - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -5.61652M 1.15M 1.15M 1.15M 1.15M
Change to liabilities - 2.65M 8.68M 0.42M -1.05272M
Total cashflows from investing activities - -7.21135M 12.94M -21.21470M 3.32M
Net borrowings - 26.15M -1.57655M -0.48183M -0.48183M
Total cash from financing activities 23.68M 25.78M 15.87M 47.73M 12.93M
Change to operating activities - 0.13M 0.34M -0.54054M -0.91519M
Net income -42.45744M -33.69047M -22.94219M -57.47931M -3.07735M
Change in cash -0.00595M -11.95040M 17.87M -0.38994M 7.03M
Begin period cash flow 15.16M 27.11M 9.23M 9.62M 0.21M
End period cash flow 15.15M 15.16M 27.11M 7.64M 0.13M
Total cash from operating activities -18.07326M -30.51720M -10.93238M -26.90684M -9.22488M
Issuance of capital stock - 0.00000M 7.61M 48.21M 0.00000M
Depreciation 1.33M 3.37M 1.03M 1.36M 0.29M
Other cashflows from investing activities - 14.82M 0.25M -0.21447M -0.21447M
Dividends paid - - - 0.00000M -
Change to inventory -3.99266M -10.34784M -2.66109M -6.83442M -2.11219M
Change to account receivables 0.23M -3.48893M -0.39697M 1.48M -1.67126M
Sale purchase of stock - 1.21M - - -
Other cashflows from financing activities - -1.57970M 3.43M 3.43M -4.31368M
Change to netincome - 4.80M 5.02M 34.69M -0.69091M
Capital expenditures 5.56M 23.18M 8.45M 7.69M 2.09M
Change receivables - -3.48893M - - -
Cash flows other operating - 6.19M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - -11.95040M - - -
Change in working capital -4.71876M -11.05166M 5.96M -5.96845M -0.00836M
Stock based compensation 2.89M 5.18M 12.78M 3.30M -
Other non cash items 16.83M 10.67M 4.83M 6.85M -
Free cash flow -23.63493M -48.56114M -19.38148M -30.14921M -0.07898M

Fundamentals

  • Previous Close 0.58
  • Market Cap34.72M
  • Volume218258
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA7.10M
  • Revenue TTM83.00M
  • Revenue Per Share TTM0.63
  • Gross Profit TTM 19.80M
  • Diluted EPS TTM-0.26

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GDNSF
Goodness Growth Holdings Inc		 0.05 7.75% 0.63 - 11.75 0.42 1.23 1.16 10.09
ZTS
Zoetis Inc		 0.68 0.39% 173.96 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.51 1.41% 36.61 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 6.91 3.93% 182.50 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.045 0.34% 13.35 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.

Goodness Growth Holdings Inc

207 South 9th Street, Minneapolis, MN, United States, 55402

Key Executives

Name Title Year Born
Dr. Kyle E. Kingsley M.D. Founder, Chairman & CEO 1975
Mr. Joshua Nathaniel Rosen Interim Pres & Director 1973
Mr. John A. Heller Chief Financial Officer 1969
Mr. Eric Greenbaum J.D. Chief Scientific Officer 1979
Ms. Amber H. Shimpa Chief Admin. Officer & Director 1979
Mr. Sam Gibbons VP of Investor Relations NA
Mr. J. Michael Schroeder Chief Compliance Officer, Company Sec. & Gen. Counsel 1967
Mr. Albert Zakes VP of Corp. Communications NA
Mr. Harris Rabin Chief Marketing Officer 1975
Dr. Stephen M. Dahmer M.D. Chief Medical Officer 1975

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).